{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-122076","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2022-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.313657+00:00","generated_at":"2026-06-21T13:06:13.175588+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Liquidia extends treprostinil promotion pact with Sandoz to 2032, adjusts profit sharing","bullets":["Third Amendment with Sandoz extends Promotion Agreement initial term to December 31, 2032.","Parties will enter a New Pump Development Agreement for subcutaneous treprostinil pump; development costs and milestones split 50/50.","Profit sharing amended: if aggregate net profits <$500M by Dec 31, 2028, Liquidia PAH receives 50% of net profits thereafter.","Indemnification terms added regarding the new pump development."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-122076","json":"https://secwatch.observer/filing/0001104659-22-122076.json","markdown":"https://secwatch.observer/filing/0001104659-22-122076.md","text":"https://secwatch.observer/filing/0001104659-22-122076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922122076/0001104659-22-122076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922122076/tm2231380d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T13:06:13.175588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9fe8d65b6c40d53d04c0f19dc087a6e34f116c77","claim":"Liquidia Corp amended Third Amendment to Promotion Agreement with Sandoz Inc. (effective 2022-11-18).","evidence_excerpt":"On November 18, 2022, Liquidia PAH, LLC, a Delaware limited liability company (formerly known as RareGen, LLC) (“Liquidia PAH”) and wholly-owned subsidiary of Liquidia Corporation, a Delaware corporation (the “Company”), entered into a Third Amendment to Promotion Agreement (the “Third Amendment”) with Sandoz Inc. (“Sandoz”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922122076/0001104659-22-122076-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"collaboration"},{"label":"Counterparty","value":"Sandoz Inc."},{"label":"Effective","value":"2022-11-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}